Statistics

Total Visits

Views
JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy-A Spanish Oncologic Genitourinary Group (SOGUG) study14

Select a period of time:

Number of views in the range

Views
JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy-A Spanish Oncologic Genitourinary Group (SOGUG) study13

Views

Views
November 20232
December 20230
January 20246
February 20240
March 20241
April 20241
May 20243
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
 

Top cities views

Views
Boardman6
Chicago3
Ashburn1